The products include OP-1 Implant, OP-1 Putty, Opgenra and Osigraft. The transaction also includes the sale of the manufacturing facility in Lebanon, N.H.
Read the Stryker release on the transaction.
Read other coverage on Stryker:
– Stryker Acquires Boston Scientific Corp.’s Neurovascular Business for $1.5B
– Stryker’s David Veino: In Support of Vertebroplasty
– Stryker Receives Two Subpoenas for Device Marketing
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
